← SynDRA
CLOBETASOL PROPIONATE
SynDRA canonical compound SYN0022323 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NR3C1 |
|---|
| Mechanism of action | Glucocorticoid receptor agonist |
|---|
| Indication | corticosteroid-responsive dermatoses |
|---|
| Disease area | dermatology |
|---|
All known targets
- NR3C1
- PLA2G1B
- ABCB11
- ANXA1
- AR
- Abcb11
- CYP3A5
- PGR
Mechanisms of action (all sources)
- NR3C1 AGONIST
- PLA2G1B INHIBITOR
Drug classes
- Corticosteroid Hormone Receptor Agonists
- Corticosteroid
- Anti-Inflammatory Agents
- Glucocorticoids
- Hormones
ATC classes
- D07A · CORTICOSTEROIDS, PLAIN
- CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS
Cross-references
Synonyms
- clobetasol 17-propionate
- clofenazon
- Clobetasol
- Clobetasol 17-propionate
- Clobecort amex
- Dovate
- Psorex
- CCI-4725
- GR-2/925
- NSC-758634
- Clarelux
- Clobaderm
- Clobetasol propionate (emollient)
- Clobex
- Cormax
- Dermovate
- Dermovate nn
- Embeline
- Embeline e
- Etrivex
- Impeklo
- Impoyz
- Olux
- Olux e
- Temovate
- Temovate e
- Clobetasolum
- Clofenazon
- Clobecort Amex
- Butavate (TN)
- Clobecort Amex (TN)
- Clobetasol (INN)
- Clobetasol [INN:BAN]
- Clobetasolum [INN-Latin]
- Clobex (TN)
- Dermatovate (TN)
- Dermovate (TN)
- Movate (TN)
Look up CLOBETASOL PROPIONATE in the interactive SynDRA portal →